Fibroblast-secreted hepatocyte growth factor mediates epidermal growth factor receptor tyrosine kinase inhibitor resistance in triple-negative breast cancers through paracrine activation of Met

INTRODUCTION: Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) have shown clinical efficacy in lung, colon, and pancreatic cancers. In lung cancer, resistance to EGFR TKIs correlates with amplification of the hepatocyte growth factor (HGF) receptor tyrosine kinase Met. Breas...

Descripción completa

Detalles Bibliográficos
Autores principales: Mueller, Kelly L, Madden, Julie M, Zoratti, Gina L, Kuperwasser, Charlotte, List, Karin, Boerner, Julie L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3680928/
https://www.ncbi.nlm.nih.gov/pubmed/22788954
http://dx.doi.org/10.1186/bcr3224

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3680928/
https://www.ncbi.nlm.nih.gov/pubmed/22788954
http://dx.doi.org/10.1186/bcr3224

Ejemplares similares